Collectively, these findings suggest GLP-1RAs may serve as dual-purpose agents by targeting both metabolic and inflammatory components of asthma by modulating arginine metabolism, reducing oxidative stress, preserving lung epithelial integrity, and counteracting inflammation-driven lung injury, with potential mechanistic insight shown in Fig
Injections are typically subcutaneous in the abdomen, thigh, or upper arm
Low potassium hypokalaemia can cause symptoms such as severe headaches, palpitations and dehydration
3. TB-500 (Thymosin Beta-4 Fragment)
The result is reduced potency and potentially altered pharmacokinetics
Typical timelines may include: Early changes: 68 weeks Visible improvement: 34 months Continued improvement with consistency Results vary depending on factors such as stress, hormones, scalp health, and overall wellness